BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell differentiation
,
Lung cancer
,
Embryo
,
DNA fingerprint
,
Doxorubicin
,
rs7903146
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
BCRP inhibitors
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for BCRP inhibitors
Explore Curated Studies Results
Literature
Most Relevant Literature
ABCG2 requires a single aromatic amino acid to "clamp" substrates and inhibitors into the binding po…
Breast Cancer Resistance Protein Limits Fetal Transfer of Tadalafil in Mice.
ABCB1 and ABCG2 Restrict Brain and Testis Accumulation and, Alongside CYP3A, Limit Oral Availability…
Magnolol derivatives as specific and noncytotoxic inhibitors of breast cancer resistance protein (BC…
Evaluation of the usefulness of breast cancer resistance protein (BCRP) knockout mice and BCRP inhib…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP)
Fruquintinib DDI Study With P-gp and BCRP Substrates
Drug Interaction Study of Safinamide and a BCRP Substrate, Diclofenac, Concomitantly Administered to…
Genetic Polymorphisms of ABCG2/BCRP on the Transport of Nifedipine to Breast Milk.
Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor Kalet…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ